{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:28:00Z","timestamp":1771514880904,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,28]],"date-time":"2018-04-28T00:00:00Z","timestamp":1524873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,28]],"date-time":"2018-04-28T00:00:00Z","timestamp":1524873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Northern Ontario School of Medicine Dean's summer student research grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2019,9,15]]},"DOI":"10.1007\/s12029-018-0108-1","type":"journal-article","created":{"date-parts":[[2018,4,28]],"date-time":"2018-04-28T00:13:06Z","timestamp":1524874386000},"page":"493-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer"],"prefix":"10.1007","volume":"50","author":[{"given":"Joey","family":"Mercier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9301-5951","authenticated-orcid":false,"given":"Ioannis A.","family":"Voutsadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,28]]},"reference":[{"key":"108_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2015","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2014an update. Cancer Epidemiol Biomark Prev. 2015;25:16\u201327.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"108_CR2","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27:5904\u201312.","journal-title":"Oncogene"},{"key":"108_CR3","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.21873\/anticanres.11145","volume":"36","author":"IA Voutsadakis","year":"2016","unstructured":"Voutsadakis IA. Immune blockade inhibition in breast cancer. Anticancer Res. 2016;36:5607\u201322.","journal-title":"Anticancer Res"},{"key":"108_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3892\/ol.2016.5487","volume":"13","author":"M Shibutani","year":"2017","unstructured":"Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative lymphocyte-to-monoocyte ratio in patients with colorectal cancer. Oncol Lett. 2017;13:1000\u20136.","journal-title":"Oncol Lett"},{"key":"108_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejogrb.2016.01.043","volume":"199","author":"G Younes","year":"2016","unstructured":"Younes G, Segev Y, Begal J, Auslender R, Goldberg Y, Amit A, et al. The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC). Eur J Gynecol Reprod Biol. 2016;199:16\u201320.","journal-title":"Eur J Gynecol Reprod Biol"},{"key":"108_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136752","volume":"10","author":"Z Su","year":"2015","unstructured":"Su Z, Mao Y-P, Ou Yang P-Y, et al. Initial hyperleukocytosis and neutrophilia in nasopharyngeal carcinoma: incidence and prognostic impact. PLoS One. 2015;10:e0136752.","journal-title":"PLoS One"},{"key":"108_CR7","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","volume":"98","author":"A Kaser","year":"2001","unstructured":"Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98:2720\u20135.","journal-title":"Blood"},{"key":"108_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366:610\u20138.","journal-title":"N Engl J Med"},{"key":"108_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4251\/wjgo.v6.i2.34","volume":"6","author":"IA Voutsadakis","year":"2014","unstructured":"Voutsadakis IA. Thrombocytosis as a prognostic marker in gastrointestinal cancers. World J Gastrointest Oncol. 2014;6:34\u201340.","journal-title":"World J Gastrointest Oncol"},{"key":"108_CR10","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/ijc.28536","volume":"134","author":"MX Li","year":"2013","unstructured":"Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2013;134:2403\u201313.","journal-title":"Int J Cancer"},{"issue":"e3837","key":"108_CR11","first-page":"95","volume":"24","author":"D Tan","year":"2016","unstructured":"Tan D, Fu Y, Su Q, Wand H. Prognostic role of platelet\u2013lymphocyte ratio in colorectal cancer\u2014a systematic review and meta-analysis. Medicine. 2016;24(e3837):95.","journal-title":"Medicine"},{"key":"108_CR12","doi-asserted-by":"crossref","unstructured":"Mercier J, Voutsadakis IA. The platelets-neutrophils to lymphocytes ratio: a new prognostic marker in metastatic colorectal cancer. J Gastrointest Oncol. 2018; (in press)","DOI":"10.21037\/jgo.2018.03.13"},{"key":"108_CR13","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/annonc\/mdx172","volume":"28","author":"H Bourgeois","year":"2017","unstructured":"Bourgeois H, Grud\u00e9 F, Solal-C\u00e9ligny P, Dupuis O, Voog E, Ganem G, et al. Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study. Ann Oncol. 2017;28:1612\u20137.","journal-title":"Ann Oncol"},{"key":"108_CR14","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1200\/JCO.2016.71.5771","volume":"35","author":"LA Renfro","year":"2017","unstructured":"Renfro LA, Goldberg RM, Grothey A, Sobrero A, Adams R, Seymour MT, et al. Clinical calculator for early mortality in metastatic colorectal cancer: an analysis of patients from 28 clinical trials in the Aide et Recherche en Canc\u00e9rologie Digestive Database. J Clin Oncol. 2017;35:1929\u201337.","journal-title":"J Clin Oncol"},{"key":"108_CR15","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252\u20139.","journal-title":"Clin Cancer Res"},{"key":"108_CR16","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125:5591\u20136.","journal-title":"J Cell Sci"},{"key":"108_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/983698","volume":"2015","author":"E Uribe-Querol","year":"2015","unstructured":"Uribe-Querol E, Rosales C. Neutrophils in cancer: two sides of the same coin. J Immunol Res. 2015;2015:983698.","journal-title":"J Immunol Res"},{"key":"108_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12307-014-0147-5","volume":"8","author":"R Vogt Sionov","year":"2015","unstructured":"Vogt Sionov R, Fridlender ZG, Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 2015;8:125\u201358.","journal-title":"Cancer Microenviron"},{"key":"108_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/j.seminoncol.2014.02.003","volume":"41","author":"CM Diaz-Montero","year":"2014","unstructured":"Diaz-Montero CM, Finke J, Montero AJ. Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications. Semin Oncol. 2014;41:174\u201384.","journal-title":"Semin Oncol"},{"key":"108_CR20","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.18632\/oncotarget.5835","volume":"7","author":"L Liang","year":"2015","unstructured":"Liang L, Zhu J, Jia H, et al. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy. Oncotarget. 2015;7:1014\u201328.","journal-title":"Oncotarget"},{"key":"108_CR21","doi-asserted-by":"publisher","first-page":"289563","DOI":"10.1155\/2013\/289563","volume":"2013","author":"A Stravodimou","year":"2013","unstructured":"Stravodimou A, Voutsadakis IA. Pre-treatment thrombocytosis as a prognostic marker in metastatic breast cancer. Int J Breast Cancer. 2013;2013:289563.","journal-title":"Int J Breast Cancer"},{"key":"108_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1477-7819-12-37","volume":"12","author":"M Kim","year":"2014","unstructured":"Kim M, Chang H, Yang HC, Kim Y, Lee CT, Lee JH, et al. Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World J Surg Oncol. 2014;12:37.","journal-title":"World J Surg Oncol"},{"key":"108_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4251\/wjgo.v9.i1.42","volume":"9","author":"M Steele","year":"2017","unstructured":"Steele M, Voutsadakis IA. Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma. World J Gastrointest Oncol. 2017;9:42\u20139.","journal-title":"World J Gastrointest Oncol"},{"key":"108_CR24","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1002\/ijc.27441","volume":"130","author":"D Buergy","year":"2012","unstructured":"Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. Int J Cancer. 2012;130:2747\u201360.","journal-title":"Int J Cancer"},{"key":"108_CR25","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2353\/ajpath.2009.090460","volume":"175","author":"B Ho-Tin-No\u00e9","year":"2009","unstructured":"Ho-Tin-No\u00e9 B, Carbo C, Demers M, Cifuni SM, Goerge T, Wagner DD. Innate immune cells induce hemorrhage in tumors during thrombocytopenia. Am J Pathol. 2009;175:1699\u2013708.","journal-title":"Am J Pathol"},{"key":"108_CR26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20:576\u201390.","journal-title":"Cancer Cell"},{"key":"108_CR27","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","volume":"69","author":"HG Kopp","year":"2009","unstructured":"Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 2009;69:7775\u201383.","journal-title":"Cancer Res"},{"key":"108_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142159","volume":"10","author":"DG Watt","year":"2015","unstructured":"Watt DG, Proctor MJ, Park JH, Horgan PG, McMillan DC. The neutrophil-platelet score (NPS) predicts survival in primary operable colorectal cancer and a variety of common cancers. PLoS One. 2015;10:e0142159.","journal-title":"PLoS One"},{"key":"108_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1506597","volume":"374","author":"P Dalerba","year":"2016","unstructured":"Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, et al. CDX2 as a prognostic biomarker in stage II and stage III colon cancer. N Engl J Med. 2016;374:211\u201322.","journal-title":"N Engl J Med"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-018-0108-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-018-0108-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-018-0108-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:05:09Z","timestamp":1628600709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-018-0108-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,28]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,15]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1007\/s12029-018-0108-1","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,28]]},"assertion":[{"value":"28 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interests"}}]}}